Michigan Collaborative Thrombosis Prevention Pilot

密歇根州协作血栓预防试点

• 批准号: 7088904
• 负责人: IVAN C HARNER
• 金额: $ 24.4万
• 依托单位: HEMOPHILIA FOUNDATION OF MICHIGAN
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-07-01 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7088904
• 关键词: blood disorder chemotherapy; cooperative study; disease /disorder prevention /control; disease /disorder proneness /risk; gene environment interaction; health education; human data; mass screening; method development; patient /disease registry; patient care management; thrombosis

The Michigan Collaborative Thrombosis Pilot(MichiganPilot)is a tri-centerproject that builds on and will expand the model of comprehensive bleeding disorders care provided by hemophilia treatment centers (HTCs) in the state of Michigan to serve patients with thrombophilia, thrombosis and thrombosis-related complications. The Hemophilia Foundationof Michigan(HFM) will administer funding and provide coordination, planning and otheradministrative support for the project. The pilot will focus on the development of a comprehensive registryof patients and clinical database to assist the Centers for Disease Control and Prevention in its efforts to better understand the genetic and environmental risk factors that contribute to thrombosis. The clinical and research sites are located in the following academic medical centers: Universityof Michigan, AnnArbor;,MichiganState University,East Lansing; Wayne StateUniversity,Detroit. Pilot sites will also work independently and collaboratively to develop adult and pediatric screening and treatment protocols to provide a framework for clinical translation research to determine optimal therapies and prevention interventions. Pilot sites will collaborate with funded sites across the country and will work with patient organizations to promote awareness about thrombosis treatment and prevention options.

密歇根州协作血栓形成试点项目（Michigan Collaborative Thrombosis Pilot）是一个三中心项目，该项目建立在并将扩展由密歇根州血友病治疗中心（HTC）提供的综合性出血性疾病护理模式，为血栓形成、血栓形成和血栓形成相关并发症患者提供服务。 密歇根血友病基金会（HFM）将管理资金，并为该项目提供协调，规划和其他行政支持。该试点项目将侧重于开发一个全面的患者登记和临床数据库，以协助疾病控制和预防中心更好地了解导致血栓形成的遗传和环境风险因素。临床和研究地点位于以下学术医疗中心：密歇根大学，安阿伯;密歇根州立大学，东兰辛;韦恩州立大学，底特律。 试点中心还将独立和合作开发成人和儿童筛查和治疗方案，为临床转化研究提供框架，以确定最佳疗法和预防干预措施。试点地点将与全国各地的资助地点合作，并将与患者组织合作，以提高对血栓形成治疗和预防选择的认识。